Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
coronavirus
archive
covid-19
abbvie
akouos
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amunix
anirvan ghosh
astrazeneca
biogen
biotech
biotechnology
bluerock therapeutics
boston blog main
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
cerovene
clinical trials
crispr
data
deals
decentralization
deerfield management
detroit blog main
detroit top stories
durvalumab
editas medicine
europe blog main
europe top stories
fda
forty seven
fred hutch
general atlantic
gilead sciences
givosiran
healthcare
What
covid
5
×
sciences
5
×
ceo
gilead
new
academy
according
acquisitions
addressed
announced
answers
arizona
big
bio
blockchain
cases
cause
centralized
chains
chance
class
collabs
conditions
coronavirus
cost
cov
daniel
data
deal
decentralization
difficulties
discovery
disease
diseases
drug
early
effect
experts
fact
faster
Language
unset
5
×
Current search:
sciences
×
unset
×
covid
×
@slashgear.com
3 years ago
COVID-19 discovery paves way for new class of non-opioid painkillers
@cointelegraph.com
3 years ago
Centralized data management hampered the global response to COVID-19
@technologyreview.com
3 years ago
Prepare for a winter covid-19 spike now, say medical experts
@slashgear.com
3 years ago
Gilead CEO answers big COVID-19 question: How much will remdesivir cost
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More